Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$ENZN - They are about a month later than normal in releasing the 10K. Wondering if it’s because they might announce an acquisition along with it? They normally release it mid February. Could be nothing but we will see soon as it has to be released by the 31st
$ENZN .089 should be a good runner soon. Carl Icahn owns nearly half of it. It has $46 million cash and $103 million NOL’s. Tiny $8 million market cap. OTCQX stock that has reached the bottom imo
$ENZN .089 should be a good runner soon. Carl Icahn owns nearly half of it. It has $46 million cash and $103 million NOL’s. Tiny $8 million market cap. OTCQX stock that has reached the bottom imo
Someone talked to the CEO a few weeks ago. Sounds like quite a few companies are interested in a deal. He doesn’t want to do a deal with just any company. They have also been reaching out to other companies as well. There was no deal with any company at that time. That is the only reason he was able to talk.
At least we know the company is actively pursuing a deal.
Any updates on this post of yours? How much longer does it have to be listed? Wonder what it has to do to remain listed?
$EMMA about to go parabolic imo. Someone bought a lot of shares today.
$EMMA .48 - I think the move higher is for real this time. Up 60% on near record volume.
How is everyone here able to buy $GVSI? Pretty big tweet by him!
Dang I didn’t even realize that till you mentioned it. It could also be Jon Couchman buying more shares. Hard telling who it is.
$GVSI just crazy this has no assets and a whopping $64,000,000 market cap. Mr Sharp only had to spend $100k and was able to turn that into over $30 million value by issuing himself preferred shares that equate to 3,000,000,000 shares of common stock.
Be careful here people!
Probably 2023 going to be a good year for this one
Don’t know why anyone would want to sell this low
$ENZN Huge potential. Just a matter of time.
$EMMA - CEO buying shares constantly. Insiders and 5%+ holders own over 78% of the company. Revenues will explode when Endari is approved in Middle East and Africa! It’s already FDA approved!
I sent you a message on Twitter. It was probably me that asked you about it lol.
I agree that it has ran a little too fast. I actually wouldn’t mind if it dropped back down so that I can pick up more shares.
I imagine the company will have a bunch of PR’s at some point. It seems like they have hired a firm that will let big investors along with institutions about Emmaus.
What’s interesting about the form PRE 14A is the split ratio to list on the Nasdaq. It requires a $4 minimum bid price. Well they said they will do either a 1-5 or 1-8 reverse split if needed sometime next year. If they did the 1-8 split at the current .47 share price, it would only get the stock up to $3.76
The company obviously knows of some kind of catalyst that will eventually move the stock higher. I’m curious as to what that could be
What price did you sell at?
$EMMA - OTCQX announced it will be up listing to the Nasdaq. Seems like this one has a ton of potential. CEO has been buying shares every week it seems like. Insiders and 5%+ holders own over 78% of the company. Even at .47 it’s market cap is low for its potential. The company is working on getting FDA approval to use Endari to treat Diverticulosis. That is a potential $8-20 Billion market in the US and a $35 billion market in the EU.
I can see why they now want to up list to the Nasdaq! The market cap is only like $23 million at .47
Also once Endari gets approved in Africa and South America, revenues will skyrocket. Company expects approval by the end of the year. It should get approved since it’s already FDA approved in the US and approved in Europe as well.
It’s no wonder why the CEO has been buying so many shares. He has bought a lot well above $1 too. The CEO even provides loans to the company when cash runs low instead of diluting the stock.
I think this is one pharma stock that will end up turning the average person into a multimillionaire IMO. The possibilities are insane.
$EMMA - Seems like this one has a ton of potential. CEO has been buying shares every week it seems like. Insiders and 5%+ holders own over 78% of the company. Even at .47 it’s market cap is low for its potential. The company is working on getting FDA approval to use Endari to treat Diverticulosis. That is a potential $8-20 Billion market in the US and a $35 billion market in the EU.
I can see why they now want to up list to the Nasdaq! The market cap is only like $23 million at .47
Also once Endari gets approved in Africa and South America, revenues will skyrocket. Company expects approval by the end of the year. It should get approved since it’s already FDA approved in the US and approved in Europe as well.
It’s no wonder why the CEO has been buying so many shares. He has bought a lot well above $1 too. The CEO even provides loans to the company when cash runs low instead of diluting the stock.
I think this is one pharma stock that will end up turning the average person into a multimillionaire IMO. The possibilities are insane.
$EMMA - Seems like this one has a ton of potential. CEO has been buying shares every week it seems like. Insiders and 5%+ holders own over 78% of the company. Even at .47 it’s market cap is low for its potential. The company is working on getting FDA approval to use Endari to treat Diverticulosis. That is a potential $8-20 Billion market in the US and a $35 billion market in the EU.
I can see why they now want to up list to the Nasdaq! The market cap is only like $23 million at .47
Also once Endari gets approved in Africa and South America, revenues will skyrocket. Company expects approval by the end of the year. It should get approved since it’s already FDA approved in the US and approved in Europe as well.
It’s no wonder why the CEO has been buying so many shares. He has bought a lot well above $1 too. The CEO even provides loans to the company when cash runs low instead of diluting the stock.
I think this is one pharma stock that will end up turning the average person into a multimillionaire IMO. The possibilities are insane.
$EMMA announced its up listing to Nasdaq. Huge potential here with its FDA approved drug. Once approved in Africa, it’s revenues will skyrocket
Oh there is no doubt we all will make good money here. I was just meaning to say that the people that are able to buy at current prices will make an insane amount of money if this goes to $1+ one day.
People that can buy this at these prices are going to be rewarded greatly
They are close IMO. Even the company has mentioned in the last filing that they hope to have things wrapped up by the end of year. They probably figure there is a potential buyer or partner out there.
Never mind, I found it:
“ After the 15c2-11 compliance date, shell companies will be able to trade for 18 months until they become an operating company. If they don't become an operating company in 18 months, they will be de-listed.”
Where does it say that he only has so long to keep it listed? I havent read anywhere it will or even could get delisted from expert market.
I think we will see some kind of news soon. Couchman hasn’t filed the annual report with the state yet. Normally he does it in may/June soon after he files Myrexis’s (which he did at his normal timing).
He might be waiting if he is currently working on a deal. He has till end of this month to file.
I’m jealous of anyone that is able to buy shares at these prices.
I think we will be surprised with a decent buyout price. Your $5-$10 estimate is very reasonable. The company has .85 per share in cash with no debt. And if we get positive results from China next week, we could easily get near $10 buyout price. If Vicineum is approved by the FDA as well, it will open up the floodgates for everything else that a Vicineum combination can be used to treat. The potential here is insane!
I don’t know why the other guy that replied thinks it’s a pump and dump. There is no one talking about $SESN right now.
I was trying to figure that out too. This happened after $SESN news yesterday about possibly selling the company. Maybe Couchman will use $MYRX to acquire $SESN for tax free income for if/when Vicineum is approved.
MYRX owns a decent chunk of ENZN shares of which gets royalty payments from SESN. Who knows though lol.
Maybe ENZN will buy out SESN
Interesting indeed. Which other expert market stock are up big like AFFY and MYRX? Wonder who is buying
I agree about the potential it has. Are you able to buy any shares? I’m trying to figure out how I can buy more at these prices.
This one ($AFFY) and $MYRX are both currently owned by the same person. Both will be good plays at some point.
Gotta good feeling we are finally close to a merger here. Fingers still crossed
And the OS remains the same. I’m surprised this isn’t multiple dollars a share yet. Great financials for sure
Yep. Someone wanted in quickly. We have to be close to an acquisition since they have been actively seeking one per the filings.
Yes, I imagine news will show up after market close today. Any unexpected positive discussions could send this back above $1 IMO
Tomorrow is their type C meeting with the FDA. $SESN
What is the best play for a Russia invasion of Ukraine?
It’s back to .41 now. I think Carl will find a great acquisition for $ENZN. The nice thing about this scenario is that Carl won’t be able to take over this company like he normally does with others. This is because of the NOL’s here. I think we are extremely close to a deal here. I know it’s been a long time waiting but I think it will pay off.